All Updates

All Updates

icon
Filter
Partnerships
Bon Vivant signs strategic partnership with Abolis Biotechnologies
Plant-based Dairy & Egg
Jun 8, 2022
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Jun 8, 2022

Bon Vivant signs strategic partnership with Abolis Biotechnologies

Partnerships

  • Bon Vivant, a France-based alternative dairy startup has signed a strategic partnership with Abolis Biotechnologies, a European specialist in synthetic biology.

  • Through the partnership, the two companies will pool their expertise and technology to produce milk proteins via precision fermentation on a large scale for use in the dairy industry.

<ul><li> Analyst QuickTake: Bon Vivant is well on its way to commercialization. This partnership comes just two months after the company raised EUR 4 million (~USD 4.3 million) in April 2022. The partnership with a European biotech leader could allow the company to attract more significant investors in the future, allowing it to accelerate the commercialization of its products while tapping into other European markets beyond France.</ul>

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.